A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice
暂无分享,去创建一个
Zhinan Yin | Lin Leng | Elias Lolis | A. Arjona | L. Leng | R. Bucala | Liang Chen | Juan Fan | Z. Yin | M. Kashgarian | H. Lan | D. Nikolic-Paterson | E. Lolis | Richard Bucala | Xin Du | Xiao-ru Huang | Xin Du | Xiao R Huang | Hui Y Lan | Liang Chen | Juan Fan | Dorothee Greven | Alvaro Arjona | David Austin | Michael Kashgarian | David Nikolic-Paterson | David Austin | D. Greven | David Austin | Xiao R. Huang
[1] Tina Peng,et al. Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.
[2] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[3] D. Busch,et al. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. , 2005, Journal of the American Society of Nephrology : JASN.
[4] Atsushi Nakagawa,et al. Crystal structure of the macrophage migration inhibitory factor from rat liver , 1996, Nature Structural Biology.
[5] M. Roman,et al. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. , 2008, The American journal of medicine.
[6] Elias Lolis,et al. The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents* , 2002, The Journal of Biological Chemistry.
[7] J. Hollander. ARTHRITIS AND ALLIED CONDITIONS , 1949 .
[8] O. Petrenko,et al. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] Peter D. Senter,et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] L R Muenz,et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.
[11] Zeny Z. Feng,et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. , 2006, Arthritis and rheumatism.
[12] E Lolis,et al. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. , 1999, Biochemistry.
[13] G. Hannon,et al. A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.
[14] P. Igarashi,et al. CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus1 , 2009, The Journal of Immunology.
[15] A. Sharpe,et al. Costimulation by B7-1 and B7-2 Is Required for Autoimmune Disease in MRL-Faslpr Mice1 , 2000, The Journal of Immunology.
[16] R. Atkins,et al. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. , 1996, The American journal of pathology.
[17] L. Leng,et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.
[18] G. Randolph,et al. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. , 1995, Journal of immunology.
[19] Zoe Cournia,et al. Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. , 2009, Journal of medicinal chemistry.
[20] J. Bernhagen,et al. The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor1 , 2009, The Journal of Immunology.
[21] T. Calandra,et al. Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.
[22] S. Onodera,et al. Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.
[23] R. Bucala,et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Tögel,et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. , 2005, Kidney international.
[25] Michael Bacher,et al. ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis* , 2005, Journal of Biological Chemistry.
[26] J. Bernhagen,et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4 , 2009, FEBS letters.
[27] Ruth R. Montgomery,et al. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. , 2007, The Journal of clinical investigation.
[28] M. Symons,et al. Rho GTPase-dependent Signaling Is Required for Macrophage Migration Inhibitory Factor-mediated Expression of Cyclin D1* , 2005, Journal of Biological Chemistry.
[29] M. González-Gay,et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus , 2006, Genes and Immunity.
[30] T. Welte,et al. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment. , 2008, The American journal of medicine.
[31] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[32] K. Meyer-Siegler,et al. Upregulation of Macrophage Migration Inhibitory Factor (MIF) and CD74, Receptor for MIF, in Rat Bladder During Persistent Cyclophosphamide-Induced Inflammation , 2008, Experimental biology and medicine.
[33] R. Holmdahl,et al. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. , 1997, Journal of immunology.
[34] L. Leng,et al. Role for macrophage migration inhibitory factor in asthma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] L. Leng,et al. MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.
[36] L. Leng,et al. Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex* , 2008, Journal of Biological Chemistry.
[37] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[38] Steffen Jung,et al. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches , 2008, Nature Immunology.
[39] E. Briganti,et al. Macrophage migration inhibitory factor in systemic lupus erythematosus. , 2004, The Journal of rheumatology.
[40] F. Nicoletti,et al. CONTROL OF THE OF THE FINAL STAGE OF IMMUNE-MEDIATED DIABETES BY ISO-1, AN ANTAGONIST OF MACROPHAGE MIGRATION INHIBITORY FACTOR , 2008 .
[41] J. M. Boswell,et al. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. , 1988, Journal of immunology.
[42] J. Bernhagen,et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.
[43] Eric M. Billings,et al. F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins , 2003, Nature Medicine.
[44] Y. D. Jong. Development of chronic colitis is dependent on the cytokine MIF , 2002, Nature Immunology.
[45] G. Fingerle-Rowson,et al. MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models , 2007, Cell Division.
[46] J. Ravetch,et al. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. , 2001, Science.
[47] B. Franke,et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. , 2005, Arthritis and rheumatism.
[48] M. Denkinger,et al. In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System , 2003, The Journal of Immunology.
[49] J. Bernhagen,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.
[50] B. Rollins,et al. Monocyte Chemoattractant Protein 1–Dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in Mrl-Faslpr Mice , 1999, The Journal of experimental medicine.
[51] R. Atkins,et al. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.
[52] G. Brayer,et al. Mapping antibody binding sites on cytochrome c with synthetic peptides: Are results representative of the antigenic structure of proteins? , 1993, Protein science : a publication of the Protein Society.
[53] R. Atkins,et al. Migration inhibitory factor expression in experimentally induced endotoxemia. , 1997, The American journal of pathology.
[54] R. Bucala,et al. The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.
[55] John David,et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[56] W. DeGrado,et al. Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists. , 1997, Journal of medicinal chemistry.
[57] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[58] J. Bernhagen,et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. , 2006, Cellular signalling.
[59] J. Bernhagen,et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.
[60] J. Bernhagen,et al. A Tautomerase-Null Macrophage Migration-Inhibitory Factor (MIF) Gene Knock-In Mouse Model Reveals That Protein Interactions and Not Enzymatic Activity Mediate MIF-Dependent Growth Regulation , 2009, Molecular and Cellular Biology.
[61] J. H. van Bockel,et al. MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease , 2009, Circulation research.
[62] H. Sabzevari,et al. G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice , 1997, European journal of immunology.